Evaluation of the Safety and Rapid Recovery Effect of the Tubeless Strategy in Lung Transplantation: a Prospective, Multicenter, Partially Double-blind, Randomized Controlled Clinical Study

NANot yet recruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

October 1, 2026

Conditions
Lung Transplant Recipient
Interventions
PROCEDURE

Tubeless Lung Transplantation Surgery

Patients undergoing this surgery receive lung transplantation surgery without standard tracheal intubation. Instead, they will breathe on their own using a special airway device called a laryngeal mask airway (LMA), combined with a bronchial blocker to separate lung ventilation during surgery. Sedation is maintained with intravenous medications (propofol, remifentanil, and dexmedetomidine), and participants will remain spontaneously breathing or receive minimal breathing assistance as needed. The surgical incision will be numbed using local anesthesia with lidocaine and ropivacaine injections. After surgery, the LMA will be removed in the operating room, and participants will transition directly to non-invasive breathing support before being monitored in the ICU.

All Listed Sponsors
collaborator

Henan Provincial People's Hospital

OTHER

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

lead

The First Affiliated Hospital of Guangzhou Medical University

OTHER